Muscle Function, Central Nervous System Sensitization, and Pain Profiling in Patients With Subacromial Pain (SAP-CNSS).
Launched by HVIDOVRE UNIVERSITY HOSPITAL · Oct 25, 2017
Trial Information
Current as of June 02, 2025
Unknown status
Keywords
ClinConnect Summary
Subacromial pain (SAP), also referred to as subacromial impingement syndrome, is characterized by pain in the shoulder joint, which is aggravated by elevation of the arm and / or during overhead activities. Subacromial pain has been suggested to be an "end station" to numerous pathologies of the shoulder and can be considered to include a variety of symptoms, and not to be seen only as a single diagnosis. In Denmark, SAP is frequently reported as a cause of pain in the shoulder joint, and based on studies from Sweden and the Netherlands, is estimated to cost the Danish society around 1.35 b...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Have had SAP during the last two weeks or more.
- • Have positive results from minimum 3 out of 5 clinical tests.
- • Have experienced pain ranking 4 or above on the VRS scale within the last 7 days.
- • Are able to speak and understand Danish.
- • Have given informed consent to participate in the study after they have fully understood the content of the study.
- Exclusion Criteria:
- • Have acquired traumatic shoulder injury, and this is onset/cause for current shoulder pain, e.g. fall on shoulder.
- • Have received a corticosteroid injection within the last six weeks.
- • Report having had a shoulder fracture within 6 months.
- • Report having had surgery on the affected shoulder.
- • Report having radiologically verified glenohumeral osteoarthritis.
- • Have a luxation or sub-luxation of the glenohumeral or the acromioclavicular joint, clinically suspected labrum lesion, clinically suspected complete traumatic tear of the rotator cuff, frozen shoulder, suspected competing diagnoses (i.e. rheumatoid arthritis, cancer, neurological disorders, and fibromyalgia).
- • Have a history of diagnosed major psychiatric disorder.
- • Have a history of illicit drug use; be currently abusing alcohol or currently withdrawing from alcohol abuse.
- • Have a history of heart disease.
- • Are pregnant.
About Hvidovre University Hospital
Hvidovre University Hospital is a leading clinical research institution located in Denmark, dedicated to advancing medical science through rigorous clinical trials and innovative healthcare solutions. As a prominent academic hospital, it integrates patient care with research, fostering collaboration among multidisciplinary teams of healthcare professionals, researchers, and academic institutions. Hvidovre University Hospital is committed to enhancing patient outcomes by conducting high-quality clinical studies across various therapeutic areas, ensuring adherence to ethical standards and regulatory compliance. Its state-of-the-art facilities and focus on translational medicine position the hospital as a key player in the development of new treatments and therapies, ultimately contributing to the improvement of public health.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Hvidovre, Sealand, Denmark
Patients applied
Trial Officials
Thomas Bandholm, PhD
Study Chair
Professor, Head of Research, PMR-C.
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials